Assessment of Cardiotoxicity With Stem Cell-based Strategies
- 1 October 2020
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 42 (10) , 1892-1910
Abstract
No abstract availableKeywords
Funding Information
- German Research Foundation
- German Centre for Cardiovascular Research
- Werner-Otto-Stiftung
- Deutsche Herzstiftung
This publication has 138 references indexed in Scilit:
- Maximum Diastolic Potential of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Depends Critically on IKrPLOS ONE, 2012
- Inter-individual Variability in the Pre-clinical Drug Cardiotoxic Safety Assessment—Analysis of the Age–Cardiomyocytes Electric Capacitance DependenceJournal of Cardiovascular Translational Research, 2012
- Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmiasFrontiers in Physiology, 2012
- Impedance-Based Detection of Beating Rhythm and Proarrhythmic Effects of Compounds on Stem Cell-Derived CardiomyocytesASSAY and Drug Development Technologies, 2011
- Pluripotent stem cell-derived cardiac tissue patch with advanced structure and functionBiomaterials, 2011
- Early afterdepolarizations and cardiac arrhythmiasHeart Rhythm, 2010
- Neuregulin/ErbB Signaling Regulates Cardiac Subtype Specification in Differentiating Human Embryonic Stem CellsCirculation Research, 2010
- Stereoselective Inhibition of the hERG1 Potassium ChannelFrontiers in Pharmacology, 2010
- Mesoscopic hydrogel molding to control the 3D geometry of bioartificial muscle tissuesNature Protocols, 2009
- Mechanisms of Cardiac Dysfunction Associated With Tyrosine Kinase Inhibitor Cancer TherapeuticsCirculation, 2008